In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention

被引:0
|
作者
Oda, Robert [1 ]
Shiramizu, Bruce [2 ]
Agsalda-Garcia, Melissa [2 ]
Kettlewell, Joanna [2 ]
Wojna, Valerie [3 ]
机构
[1] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA
[2] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI USA
[3] Univ Puerto Rico, Neurol Div, Dept Med, Med Sci Campus, San Juan, PR 00936 USA
关键词
HIV; Cognition; Blood-brain barrier; Neurocognition; Brain; MONOCYTES; DNA; DEMENTIA; HAART;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: HIV-associated cognitive impairment (HACI) continues to persist for HIV-seropositive individuals who are on antiretroviral therapy (ART). HACI develops in part when HIV-infected monocytes (MOs) transmigrate through the blood-brain barrier (BBB) and secrete pro-inflammatory cytokines and chemokines, which leads to neuronal damage. In vitro BBB models are important tools that can elucidate mechanisms of MO transmigration. Previously described in vitro BBB models relied on pathology specimens, resulting in potentially variable and inconsistent results. This project reports on a reliable and consistent alternative in vitro BBB model that has the potential to be used in clinical research intervention studies analyzing the effects of ART on the BBB and on MO transmigration. Methods: A bilayer BBB model was established with commercially available astrocytes and endothelial cells on a 3 mu m PET membrane insert to allow the contact of astrocytic foot processes with endothelial cells. Inserts were cultured in growth medium for 7 days before exposure to HIV- or HIV+ peripheral blood mononuclear cells (PBMCs). PBMCs were allowed to transmigrate across the BBB for 24 hours. Results: Confluency and integrity measurements by trans-endothelial electrical resistance (TEER) (136.7 +/- 18.3 Omega/cm(2)) and permeability (5.64 +/- 2.20%) verified the integrity of the in vitro BBB model. Transmigrated MOs and non-MOs were collected and counted (6.0x10(4) MOs; 1.1x10(5) non-MOs). Markers indicative of glial fibrillary acidic protein (GFAP), von Willebrand factor (vWF), and p-glycoprotein (Pgp) were revealed in immunofluorescence staining (IF), indicating BBB phenotype and functionality. Conclusion: Potential applications for this model include assessing the HIV DNA copy numbers of transmigrated cells (pre- and post-targeted ART) and understanding the role of oxidative stress related to HIV DNA and HACI.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 50 条
  • [21] Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models
    Stefan Lundquist
    Mila Renftel
    Julien Brillault
    Laurence Fenart
    Roméo Cecchelli
    Marie-Pierre Dehouck
    Pharmaceutical Research, 2002, 19 : 976 - 981
  • [22] Modeling of Blood-Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research
    Ohbuchi, Masato
    Shibuta, Mayu
    Tetsuka, Kazuhiro
    Sasaki-Iwaoka, Haruna
    Oishi, Masayo
    Shimizu, Fumitaka
    Nagasaka, Yasuhisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [23] Modulating CCl5-driven mononuclear cell migration across the blood-brain barrier in vitro: implications for MS therapy
    Ubogu, E. E.
    Callahan, M. K.
    Tucky, B. H.
    Ransohoff, R. M.
    MULTIPLE SCLEROSIS, 2007, 13 (02): : 302 - 302
  • [24] Blood Brain Barrier Impairment in HIV-Positive Na⟨ve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
    Calcagno, A.
    Romito, A.
    Atzori, C.
    Ghisetti, V.
    Cardellino, C.
    Audagnotto, S.
    Scarvaglieri, E.
    Lipani, F.
    Imperiale, D.
    Di Perri, G.
    Bonora, S.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 (01) : 187 - 193
  • [25] Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
    A. Calcagno
    A. Romito
    C. Atzori
    V. Ghisetti
    C. Cardellino
    S. Audagnotto
    E. Scarvaglieri
    F. Lipani
    D. Imperiale
    G. Di Perri
    S. Bonora
    Journal of Neuroimmune Pharmacology, 2017, 12 : 187 - 193
  • [26] Identification of Blood-Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase
    Sato, Kazuki
    Tachikawa, Masanori
    Watanabe, Michitoshi
    Miyauchi, Eisuke
    Uchida, Yasuo
    Terasaki, Tetsuya
    MOLECULAR PHARMACEUTICS, 2019, 16 (01) : 247 - 257
  • [27] In Vitro Primary Human and Animal Cell-Based Blood-Brain Barrier Models as a Screening Tool in Drug Discovery
    Lacombe, Olivier
    Videau, Orianne
    Chevillon, Delphine
    Guyot, Anne-Cecile
    Contreras, Christelle
    Blondel, Sandrine
    Nicolas, Laurence
    Ghettas, Aurelie
    Benech, Henri
    Thevenot, Etienne
    Pruvost, Alain
    Bolze, Sebastien
    Krzaczkowski, Lucie
    Prevost, Colette
    Mabondzo, Aloise
    MOLECULAR PHARMACEUTICS, 2011, 8 (03) : 651 - 663
  • [28] New in vitro model of the blood-brain barrier: From nanofabrication and the culture of murine brain microvascular endothelial cells to drug transport
    Shayan, Gilda
    Shuler, Michael L.
    Shusta, Eric
    Ober, Christoper K.
    Lee, Kelvin H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [29] Human induced pluripotent stem cell modeling of the blood-brain barrier identifies intrinsic barrier dysfunction in multiple sclerosis patients
    Nishihara, H.
    Perriot, S.
    Gastfriend, B. D.
    Mathias, A.
    Palecek, S. P.
    Shusta, E. V.
    Du Pasquier, R.
    Engelhardt, B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 15 - 15
  • [30] Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro
    De Laere, Maxime
    Sousa, Carmelita
    Meena, Megha
    Buckinx, Roeland
    Timmermans, Jean-Pierre
    Berneman, Zwi
    Cools, Nathalie
    MEDIATORS OF INFLAMMATION, 2017, 2017